Modulation of transcription factor NF-κB in Hodgkin's lymphoma cell lines: Effect of (−)-epicatechin

References

• Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301–310
   PubMed Web of Science ®Google Scholar
• Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999; 18: 6938–6947
   PubMed Web of Science ®Google Scholar
• Cahir McFarland ED, Izumi KM, Mosialos G. Epstein-barr virus transformation: Involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 1999; 18: 6959–6964
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Baltimore D. I kappa B: A specific inhibitor of the NF-kappa B transcription factor. Science 1988; 242: 540–546
   PubMed Web of Science ®Google Scholar
• Delhase M, Hayakawa M, Chen Y, Karin M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 1999; 284: 309–313
   PubMed Web of Science ®Google Scholar
• Karin M, How M. NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex. Oncogene 1999; 18: 6867–6874
   PubMed Web of Science ®Google Scholar
• Aggarwal BB. Nuclear factor-kappaB: The enemy within. Cancer Cell 2004; 6: 203–208
   PubMed Web of Science ®Google Scholar
• Karin M, Greten FR. NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749–759
   PubMed Web of Science ®Google Scholar
• Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF-kappaB is the answer—role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003; 22: 8961–8982
   PubMed Web of Science ®Google Scholar
• Lin A, Karin M. NF-kappaB in cancer: A marked target. Semin Cancer Biol 2003; 13: 107–114
   PubMed Web of Science ®Google Scholar
• Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999; 18: 6853–6866
   PubMed Web of Science ®Google Scholar
• Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461–466
   PubMed Web of Science ®Google Scholar
• Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B. Constitutive nuclear factor-kappaB–RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997; 100: 2961–2969
   PubMed Web of Science ®Google Scholar
• Horie R, Watanabe T. The biological basis of Hodgkin's lymphoma. Drug News Perspect 2003; 16: 649–656
   PubMedGoogle Scholar
• Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dorken B, Scheidereit C. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 1999; 18: 943–953
   PubMed Web of Science ®Google Scholar
• Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, Mathas S, Krappmann D, Scheidereit C, Stein H, Dorken B. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the IkappaB alpha gene in Reed-Sternberg cells. Blood 1999; 94: 3129–3134
   PubMed Web of Science ®Google Scholar
• Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 1999; 18: 3063–3070
   PubMed Web of Science ®Google Scholar
• Jungnickel B, Staratschek-Jox A, Brauninger A, Spieker T, Wolf J, Diehl V, Hansmann ML, Rajewsky K, Kuppers R. Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 2000; 191: 395–402
   PubMed Web of Science ®Google Scholar
• Emmerich F, Theurich S, Hummel M, Haeffker A, Vry MS, Dohner K, Bommert K, Stein H, Dorken B. Inactivating IkappaBepsilon mutations in Hodgkin/Reed-Sternberg cells. J Pathol 2003; 201: 413–420
   PubMed Web of Science ®Google Scholar
• Martin-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B, Grote W, Novo FJ, Calasanz MJ, Hansmann ML, Dyer MJ, Siebert R. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002; 99: 1474–1477
   PubMed Web of Science ®Google Scholar
• Horie R, Watanabe T, Morishita Y, Ito K, Ishida T, Kanegae Y, Saito I, Higashihara M, Mori S, Kadin ME, Watanabe T. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin–Reed-Sternberg cells. Oncogene 2002; 21: 2493–2503
   PubMed Web of Science ®Google Scholar
• Hammarskjold ML, Simurda MC. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J Virol 1992; 66: 6496–6501
   PubMed Web of Science ®Google Scholar
• Graf BA, Milbury PE, Blumberg JB. Flavonols, flavones, flavanones and human health: epidemiological evidence. J Med Food 2005; 8: 281–290
   PubMed Web of Science ®Google Scholar
• Hou Z, Sang S, You H, Lee MJ, Hong J, Chin KV, Yang CS. Mechanism of action of ( − )-epigallocatechin-3-gallate: Auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res 2005; 65: 8049–8056
   PubMed Web of Science ®Google Scholar
• Leone M, Zhai D, Sareth S, Kitada S, Reed JC, Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res 2003; 63: 8118–8121
   PubMed Web of Science ®Google Scholar
• Vayalil PK, Mittal A, Katiyar SK. Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NFkappaB. Carcinogenesis 2004; 25: 987–995
   PubMed Web of Science ®Google Scholar
• Zhao J, Wang J, Chen Y, Agarwal R. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation–promotion protocol and identification of procyanidin B5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis 1999; 20: 1737–1745
   PubMed Web of Science ®Google Scholar
• Park YC, Rimbach G, Saliou G, Valacchi G, Packer L. Activity of monomeric, dimeric and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages. FEBS Lett 2000; 465: 93–97
   PubMed Web of Science ®Google Scholar
• Saliou C, Valacchi G, Rimbach G. Assessing bioflavonoids as regulators of NF-kappaB activity and inflammatory gene expression in mammalian cells. Meth Enzymol 2001; 335: 380–387
   PubMed Web of Science ®Google Scholar
• Surh YJ, Kundu JK, Na HK, Lee JS. Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J Nutr 2005; 135: 2993S–3001S
   PubMed Web of Science ®Google Scholar
• Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 1998; 128: 2334–2340
   PubMed Web of Science ®Google Scholar
• Mackenzie GG, Carrasquedo F, Delfino JM, Keen CL, Fraga CG, Oteiza PI. Epicatechin, catechin and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. Faseb J 2004; 18: 167–169
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Nomura M, Ma W, Chen N, Bode AM, Dong Z. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, ( − )-epigallocatechin gallate and theaflavins. Carcinogenesis 2000; 21: 1885–1890
   PubMed Web of Science ®Google Scholar
• Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M. ( − )-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 2006; 103: 1024–1029
   PubMed Web of Science ®Google Scholar
• Tsang C, Auger C, Mullen W, Bornet A, Rouanet JM, Crozier A, Teissedre PL. The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Br J Nutr 2005; 94: 170–181
   PubMed Web of Science ®Google Scholar
• Natsume M, Osakabe N, Yasuda A, Baba S, Tokunaga T, Kondo K, Osawa T, Terao J. In vitro antioxidative activity of ( − )-epicatechin glucuronide metabolites present in human and rat plasma. Free Radic Res 2004; 38: 1341–1348
   PubMed Web of Science ®Google Scholar
• Williamson G, Barron D, Shimoi K, Terao J. In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res 2005; 39: 457–469
   PubMed Web of Science ®Google Scholar
• Hinz M, Lemke P, Anagnostopoulos I, Hacker C, Krappmann D, Mathas S, Dorken B, Zenke M, Stein H, Scheidereit C. Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 2002; 196: 605–617
   PubMed Web of Science ®Google Scholar
• Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C. Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 2001; 97: 2798–2807
   PubMed Web of Science ®Google Scholar
• Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995; 270: 14255–14258
   PubMed Web of Science ®Google Scholar
• Song A, Nikolcheva T, Krensky AM. Transcriptional regulation of RANTES expression in T lymphocytes. Immunol Rev 2000; 177: 236–245
   PubMed Web of Science ®Google Scholar
• Falvo JV, Uglialoro AM, Brinkman BM, Merika M, Parekh BS, Tsai EY, King HC, Morielli AD, Peralta EG, Maniatis T, Thanos D, Goldfeld AE. Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol Cell Biol 2000; 20: 2239–2247
   PubMed Web of Science ®Google Scholar
• Bowie A, O'Neill LA. Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000; 59: 13–23
   PubMed Web of Science ®Google Scholar
• Ginn-Pease ME, Whisler RL. Redox signals and NF-kappaB activation in T cells. Free Radic Biol Med 1998; 25: 346–361
   PubMed Web of Science ®Google Scholar
• Li N, Karin M. Is NF-kB the sensor of oxidative stress?. FASEB J. 1999; 13: 1137–1143
   PubMed Web of Science ®Google Scholar
• Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. Faseb J 1996; 10: 709–720
   PubMed Web of Science ®Google Scholar
• Moran LK, Gutteridge JM, Quinlan GJ. Thiols in cellular redox signalling and control. Curr Med Chem 2001; 8: 763–772
   PubMed Web of Science ®Google Scholar
• Arrigo AP. Gene expression and the thiol redox state. Free Radic Biol Med 1999; 27: 936–944
   PubMed Web of Science ®Google Scholar
• Singh R, Ahmed S, Islam N, Goldberg VM, Haqqi TM. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: Suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum 2002; 46: 2079–2086
   PubMed Web of Science ®Google Scholar
• Sen P, Chakraborty PK, Raha S. Tea polyphenol epigallocatechin 3-gallate impedes the anti-apoptotic effects of low-grade repetitive stress through inhibition of Akt and NFkappaB survival pathways. FEBS Lett 2006; 580: 278–284
   PubMed Web of Science ®Google Scholar
• Lotito SB, Actis-Goretta L, Renart ML, Caligiuri M, Rein D, Schmitz HH, Steinberg FM, Keen CL, Fraga CG. Influence of oligomer chain length on the antioxidant activity of procyanidins. Biochem Biophys Res Commun 2000; 276: 945–951
   PubMed Web of Science ®Google Scholar
• Han D, Handelman G, Marcocci L, Sen CK, Roy S, Kobuchi H, Tritschler HJ, Flohe L, Packer L. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 1997; 6: 321–338
   PubMed Web of Science ®Google Scholar
• Packer L. alpha-Lipoic acid: A metabolic antioxidant which regulates NF-kappaB signal transduction and protects against oxidative injury. Drug Metab Rev 1998; 30: 245–275
   PubMed Web of Science ®Google Scholar
• Roy S, Packer L. Redox regulation of cell functions by alpha-lipoate: Biochemical and molecular aspects. Biofactors 1998; 7: 263–267
   PubMedGoogle Scholar
• Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: Implications in cancer and inflammation. Trends Biochem Sci 2005; 30: 43–52
   PubMed Web of Science ®Google Scholar
• Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 2005; 7: 1630–1647
   PubMed Web of Science ®Google Scholar
• Long LH, Clement MV, Halliwell B. Artifacts in cell culture: Rapid generation of hydrogen peroxide on addition of ( − )-epigallocatechin, ( − )-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media. Biochem Biophys Res Commun 2000; 273: 50–53
   PubMed Web of Science ®Google Scholar